Indian Drug Company To Copy Roche Flu Drug
Indian drug maker Cipla said it would initiate production of the drug regardless of whether Roche grants the company a license.
"Right or wrong, we are going to commercialize and make Oseltamivir," Yusuf K. Hamied, chairman of Mumbai-based Cipla, told The New York Times. Oseltamivir is the drug’s generic name....
To view the full article, register now.